Journals
Publish with us
Publishing partnerships
About us
Blog
Journal of Oncology
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Journal of Oncology
/
2022
/
Article
/
Tab 6
/
Research Article
Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag
Table 6
COX univariate analysis.
Features
SE
Wald
Df
Gender
-1.135
0.7157
2.514
1
0.1128
0.3214
Age
1.891
1.004
3.551
1
0.0595
6.629
Smoking history
-0.5602
0.7181
0.6085
1
0.4353
0.5711
TNM stage
3.812
1.175
10.53
1
0.0012
45.25
Number of tumors
1.320
0.9133
2.089
1
0.1483
3.744
Line of medication
2.122
0.9933
4.566
1
0.0326
8.352
Histology types
0.7421
1.000
0.5511
1
0.4579
2.101